Derek Jackson
IAM × OPENLOOP × RIHANNA
A partnership built to be owned, not rented.
CONFIDENTIAL · CONCEPT v0.1 · PREPARED FOR DISCUSSION · AUGUST 2026
Fenty Wellness is an internal creative sample pending production governance sign-off.
SECTION 1 · WHY WE'RE HERE
Before market size or money, the only question that matters: who are these people, how are they connected, and why should Rihanna be in business with them.
WHO WE ARE · THE BRIDGE
IAM, Intellectual Asset Management, builds companies around a talent's IP: their name, audience, and credibility. Instead of talent renting out their name for a one-time endorsement fee, IAM structures an actual business around it; the talent holds equity, earns recurring revenue, and gets paid again if the company is sold.
IAM is a resource for management. Management holds the mandate to guide the talent's success; IAM is engaged to execute a specific part of that mandate — building the recurring-revenue business.
An endorsement is a fee, paid once, for attention. A membership business is revenue, paid every month, because it's built on trust. IAM builds the second kind.
equity, distributions, participation at exit.
nothing carrying her name ships without her sign-off.
no posting quota; judgment and signal, not labor.
proven operators, institutional capital, underwritten first.
IAM is the bridge: talent-side judgment on one side, a national medical operator on the other. We connect Rihanna's world to OpenLoop's medicine and make sure the company that results is hers.
The operating bench connecting talent-side trust, growth, finance, and healthcare execution.
Case Studies
GOAT Foods
TRUKFIT
Lion X
WHO WE ARE · THE ENGINE
OpenLoop is a white-label medical operator — the clinical engine behind major direct-to-consumer health brands (the Hims and Fridays of the category). They handle everything a health company is afraid of: clinicians, prescriptions, pharmacy, compliance, patient support, billing, technology. Rihanna never touches the medicine. She owns the brand; they run the rest.
OpenLoop has always powered B2B health brands. This is the first time they're building around a person's audience instead of buying one — and Rihanna's trust is the most valuable version of that. Call any brand on their platform and ask about them; the numbers hold up.
WHY RIHANNA · MEASURED, NOT MARKETED
WHY RIHANNA · MEASURED, NOT MARKETED
Fenty's entire thesis was that the category ignored people's real differences and shipped 40 shades instead of 4. Diagnostics is that same argument, moved into medicine: stop guessing, measure. It converts every existing Fenty complaint into a finding — the shedding is a ferritin number, the fatigue is a TSH number, the dullness is a vitamin D number. And because a clinician reads the panel before anything is sold, the stack is a care plan, not a celebrity supplement line. That is the entire difference between this being credible and being another Goop.
We're not attaching Rihanna to a category she hasn't lived. She said it herself — the way she started losing her hair "was not on the pamphlet." She's 38; her core audience is aging into perimenopause alongside her — the exact place where hair, skin, sleep, mood, and weight all converge. She's spoken openly about mental health as a necessity, about mom guilt and the fear of postpartum depression, about running on "sleep pockets" with three kids under four. None of this is a media buy. It's a life her audience already trusts her to narrate.
"We're not here to tell Rihanna what to promote. We're here to show her what she can — and build it around what's already measured about her."
THE PROCESS · THE FINDING IS THE OUTPUT, NEVER THE PITCH
Nothing here is pre-decided. We don't hand Rihanna a finished product; we build it with her, in four steps — and the diagnostic panel comes before anything is ever sold.
We learn how Rihanna actually lives, what she already uses, and what she'd want for herself and her audience. Her team sees the full OpenLoop platform, so both sides can identify what feels authentic — and where the Diagnostic Spectrum becomes the brand's measurement language.
OpenLoop's medical team designs the mix around what's real to Rihanna, anchored on the whole-health diagnostic panel as the spine. She approves every product; she can launch with the diagnostic hero alone or a broader line.
Before launch, Rihanna understands the medicine and the compliant messaging lane. She can speak from experience — and from her own numbers — without making claims she legally can't.
Then we go live. Her audience drives the first wave organically; the business compounds through diagnostic membership, nutraceutical cycles, and quarterly refreshes.
Partner-side reference economics — illustrative, not a guarantee.
Full table
| Line | Retail | Partner-side | Cadence |
|---|---|---|---|
| Whole Health Diagnostics + Nutraceuticals (spine) | Starter $199 · Full Annual $396 | ~$147 annual + ~$356 nutraceutical cycles (4×$89) + ~$153 refreshes (3×$51) ≈ ~$656/member/yr | Annual + quarterly, before vertical upsell ($45–185/mo) |
| Dermatology — Tone & Hyperpigmentation | $45 / $40 / $36 per mo (12 / 24 / 52 wk) | $56 / $108 / $189; ~40% of patient spend on 52-wk | Async primary + 12-wk async refills |
| Women's Hair Loss | $70/4wk (NextGen) · $55/mo 48-wk ($660) · $75/4wk · $69/mo 24-wk | $38 · $228 · $31 · $201 | Async 24-wk refill |
| Perimenopause / Female HRT | $79/mo · $149/mo (testosterone) · $198/mo (HRT+TRT) | $90/12wk (~$360/yr) · $233/12wk (~$932/yr) · $297/12wk (~$1,188/yr, labs incl.) | Async primary, quarterly refills |
| Mental Health Therapy | $774 (6-pack) · $149 one-off | $198 · $48 | Per consult |
| Sleep — diagnostic ring + therapy | Insurance-covered ring (~$20–25 copay) or $33/mo cash · $149 therapy · $33–63/mo meds | $150 intake · $48 therapy · $34/cycle meds | Intake + refills; non-GLP-1 & therapy only |
This is ownership, not a fee. Rihanna holds a founder's position: equity, monthly distributions while the business runs, and participation at exit. IAM builds and operates alongside her; OpenLoop runs the medicine.
Final terms structured together.
The pink-diamond standard of care — built around trust Rihanna already owns.
Appendix
Product examples are directional only. The mix is discovered with Rihanna.
Appendix · Product examples
These are not the pitch. They are reference points for the immersion — categories OpenLoop can operationalize if they prove authentic to Rihanna. The diagnostic panel is the spine; everything else hangs off a finding.

A clinician reads a full panel before anything is sold, then a personalized nutraceutical stack is built to the findings — a care plan, not a supplement line.
Starter $199 / Full Annual $396 retail; recurring cycles + quarterly refreshes.
Clinically the pigmentation stack — the single most underserved derm need in deeper skin tones. Plus acne, rosacea, and women's facial-hair reduction.
$36–45/mo by term; async primary + refills.
The clinical completion of Fenty Hair. Female-specific formulations — the one line where her own words are the ad copy.
from $31/4wk; 24–48-wk terms; low-friction async refills.Where hair, skin, sleep, mood, and weight converge — native to the diagnostic panel (FSH, LH, SHBG, prolactin already on Core). Underserved, high willingness to pay, zero body-shame exposure.
from $79/mo; quarterly refills; highest recurring margin.
Brand-safe, no appearance risk. Grounded in what she's already said about making time for herself, mom guilt, and PPD.
$129/consult in a 6-pack; $149 one-off."Sleep pockets," three kids under four — highly relatable, and the FDA-cleared, insurance-covered ring is a genuinely differentiated hook.
intake on insurance-covered device (~$20–25 copay) or cash; therapy + non-sedative pathways.Appendix · Brand direction
Fenty Wellness remains an internal creative sample pending production governance sign-off. The direction stays warm-black, gold-foil, unapologetic, and measured — never hospital-blue, never clinical-white, never body-shaming.
CONFIDENTIAL · CONCEPT v0.1 · PREPARED FOR DISCUSSION · AUGUST 2026. Prepared for discussion purposes only. Prescription products require an evaluation with a licensed clinician; availability varies by state. Individual results vary. Compounded medications are prepared by licensed pharmacies and are not FDA-approved.